Lineage Cell Therapeutics, Inc. (LCTX)
1.70
+0.05
(+3.03%)
USD |
NYAM |
Jan 16, 16:00
1.705
0.00 (0.00%)
Pre-Market: 20:00
Lineage Cell Therapeutics Price: 1.70 for Jan. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ocugen, Inc. | 1.69 |
| Belite Bio, Inc. | 155.11 |
| ProKidney Corp. | 2.29 |
| CEL-SCI Corp. | 5.15 |
| AIM ImmunoTech, Inc. | 1.34 |
Price Related Metrics
| PS Ratio | 35.51 |
| PEG Ratio | -0.0338 |
| Price to Book Value | 17.77 |
| Earnings Yield | -17.45% |
| Market Cap | 391.56M |
| PEGY Ratio | -0.0338 |